A Study To Evaluate Efficacy Of Unani Formulation In The Management Of Cervical Spondylosis (Waja-al-Unuq)

A Clinical Study to Evaluate the Efficacy and Safety of Unani Formulation in the Management of Waja-al-Unuq (Cervical Spondylosis)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/090665

Enrollment

Registered

2025-07-10

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M478- Other spondylosis

Interventions

Intervention1: Unani poly herbal formulations Roghan-e-zanjabeel : Unani poly herbal formulations Dosage Form: Safuf (Powder) Dose : 4 gm twice daily Route of administration: Oral Roghan-e-Zanjab

Eligibility

Inclusion criteria

Inclusion criteria: 1. Clinically stable patient having complain of Cervical spondylosis (neck pain tenderness paraesthesia or numbness and restricted movement of neck). 2. Radiologically diagnosed patients of Waja-al-Unuq (C.S) Using Kettlers Grading Scale based on cervical disc degeneration (with the concern of radiologist). 3. Patients belonging to 25 to 60 years of age in both sexes 4. Patients able to participate in the study and ready to follow the instructions and sign the consent form

Exclusion criteria

Exclusion criteria: 1. Pregnancy, lactating mothers and women using OCPs drug. 2. Spinal tumour or cancer. 3. Any post healed cervical fracture, congenital spinal deformity. 4. Patients having systemic as well as metabolic diseases like liver, kidney, Cardiac, pulmonary diseases, Epilepsy, Diabetes and HTN. 5. Patient taking corticosteroids. 6. Cervical rib syndrome. 7. Raw skin lesion on neck. 8. Patients unsure about attending treatment schedule regularly. 9. Patients with the history of trauma and accidents. 10. Patients suffering from immunological diseases like HIV, hepatitis and malignancy. 11. Grade 3 scale of Kettler s Grading System.

Design outcomes

Primary

Measure	Time frame
1.Improvement in Patient s Global Assessment on VAS 2.Improvement in Clinical symptoms on Likert ScaleTimepoint: Clinical assessment will be done at Baseline, 2nd, 4th, 6th and 8th weeks.	—

Secondary

Measure	Time frame
Reduction in Kettlers Grading System.Timepoint: Clinical assessment will be done at Baseline & 8th weeks.	—

Countries

India

Contacts

Public ContactDr Gulnaz Fatima

State Takmeel ut Tib College And Hospital

mzaligmd@gmail.com8318016554

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026